tiprankstipranks
Trending News
More News >

Sumitomo Pharma Restructures Asian Business with Marubeni Partnership

Story Highlights
Sumitomo Pharma Restructures Asian Business with Marubeni Partnership

Don’t Miss TipRanks’ Half-Year Sale

An announcement from Sumitomo Dainippon Pharma Co ( (JP:4506) ) is now available.

Sumitomo Pharma Co., Ltd. has announced a strategic restructuring of its Asian business through a simplified absorption-type company split. This involves transferring 60% of shares of a newly established subsidiary to Marubeni Global Pharma Corporation, with the option to transfer the remaining 40% in the future. This move is expected to enhance Sumitomo Pharma’s operational focus and market positioning in Asia, potentially impacting stakeholders by aligning with Marubeni’s resources and market reach.

The most recent analyst rating on (JP:4506) stock is a Hold with a Yen460.00 price target. To see the full list of analyst forecasts on Sumitomo Dainippon Pharma Co stock, see the JP:4506 Stock Forecast page.

More about Sumitomo Dainippon Pharma Co

Sumitomo Pharma Co., Ltd. operates in the pharmaceutical industry, focusing on the manufacturing and sales of pharmaceuticals. The company is engaged in expanding its market presence, particularly in Asia, through strategic partnerships and restructuring efforts.

Average Trading Volume: 8,399,681

Technical Sentiment Signal: Buy

Current Market Cap: Yen311.1B

For a thorough assessment of 4506 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1